Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
Status:
Terminated
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
Provide adefovir dipivoxil (Hepsera) 10 mg once daily to patients with chronic hepatitis B
virus (HBV) infection who have completed a Gilead-sponsored study of adefovir dipivoxil and
require continued access to adefovir dipivoxil.